Behavioral arousal and increased dopamine efflux after blockade of NMDA-receptors in the prefrontal cortex are dependent on activation of glutamatergic neurotransmission

Neuropharmacology

Volumn 42, Issue 6, 2002, Pages 752-763

  Feenstra, M G P ^a   Botterblom, M H A ^a   van Uum, J F M ^a  

^a NETHERLANDS INSTITUTE FOR NEUROSCIENCE   (Netherlands)

Author keywords

D AP 5; Dopamine efflux; Microdialysis; Noradrenaline efflux; Nucleus accumbens; Schizophrenia

Indexed keywords

4 AMINOBUTYRIC ACID B RECEPTOR; DOPAMINE; DOPAMINE 1 RECEPTOR; DOPAMINE 2 RECEPTOR; GLUTAMATE RECEPTOR; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; N METHYL DEXTRO ASPARTIC ACID RECEPTOR BLOCKING AGENT;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL TISSUE; AROUSAL; ARTICLE; BEHAVIOR; BRAIN PERFUSION; CONCENTRATION RESPONSE; CONTROLLED STUDY; DOPAMINERGIC SYSTEM; EFFUSION; MALE; MOTOR ACTIVITY; NEUROTRANSMISSION; NONHUMAN; NUCLEUS ACCUMBENS; PREFRONTAL CORTEX; PRIORITY JOURNAL; RAT; RECEPTOR BLOCKING; REGULATORY MECHANISM;

ANIMALS; AROUSAL; DOPAMINE; EXCITATORY AMINO ACID ANTAGONISTS; MALE; MOTOR ACTIVITY; PREFRONTAL CORTEX; RATS; RATS, WISTAR; RECEPTORS, DOPAMINE; RECEPTORS, GABA-B; RECEPTORS, GLUTAMATE; RECEPTORS, N-METHYL-D-ASPARTATE;

EID: 0036092340     PISSN: 00283908     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0028-3908(02)00029-1     Document Type: Article

References (51)

1. The NMDA antagonist model for schizophrenia: Promise and pitfalls
2. Corticolimbic dopamine neurotransmission is temporally dissociated from the cognitive and locomotor effects of phencyclidine
3. Fos expression following self-stimulation of the medial prefrontal cortex
4. Blockade of NMDA receptors located at the dorsomedial prefrontal cortex impairs spatial working memory in rats
5. Homovanillic acid in rat caudate and prefrontal cortex following phencyclidine and amphetamine
6. Association of ketamine-induced psychosis with focal activation of the prefrontal cortex in healthy volunteers
7. Neuronal firing in the nucleus accumbens is associated with the level of cortical arousal
8. Rewarding actions of phencyclidine and related drugs in nucleus accumbens shell and frontal cortex
9. Central sympathomi-metic activity of (+)-5-methyl-10,11-dihydro-5H-dibenzo[a, d]cyclohepten-5,10-imine (MK-801), a substance with potent anticonvulsant, central sympathomime-tic, and apparent anxiolytic properties
10. Neuronal and glial localization of NMDA receptors in the cerebral cortex
11. D-Serine antagonized phencyclidine- and MK-801-induced stereotyped behavior and ataxia
12. Presynaptic NMDA receptors in the neocortex are both auto- and heteroreceptors
13. Antagonism of the hypermotility response induced by excitatory amino acids in the rat nucleus accumbens
14. Concentration-dependent dual action of locally applied N-methyl-D-aspartate on extracellular dopamine in the rat prefrontal cortex in vivo
15. Local activation of metabotropic glutamate receptors inhibits the handling-induced increased release of dopamine in the nucleus accumbens but not that of dopamine and noradrenaline in the prefrontal cortex: Comparison with inhibition of ionotropic receptors
16. Dopamine and noradrenaline efflux in the prefrontal cortex in the light and dark period: Effects of novelty and handling and comparison to the nucleus accumbens
17. Presynaptic effect of L-glutamic acid on the release of dopamine in rat striatal slices
18. Phencyclidine (PCP)
19. The specificity of the 'nonspecific' midline and intralaminar thalamic nuclei
20. Quantitative studies on some antagonists of N-methyl D-aspartate in slices of rat cerebral cortex
21. Evidence for involvement of N-methyl-D-aspartate receptor in tonic inhibitory control of dopaminergic transmission in rat medial frontal cortex
22. The non-NMDA glutamate receptor antagonist GYKI 52466 counteracts locomotor stimulation and anticataleptic activity induced by the NMDA antagonist dizocilpine
23. Trans-striatal dialysis coupled to reverse phase high performance liquid chromatography with electrochemical detection: A new method for the study of the in vivo release of endogenous dopamine and metabolites
24. Interactions between excitatory amino acids and dopamine systems in the forebrain: Implications for schizophrenia and Parkinson's disease
25. Prefrontal cortical involvement in phencyclidine-induced activation of the mesolimbic dopamine system: Behavioral and neurochemical evidence
26. The neuropsychopharmacology of phencyclidine: From NMDA receptor hypofunction to the dopamine hypothesis of schizophrenia
27. Glutamate stimulates dopamine release from cortical and limbic rat brain in vitro
28. Extracellular release of acetylcholine, noradrenaline and serotonin increases in the cerebral cortex during walking in conscious rats
29. Ketamine activates psychosis and alters limbic blood flow in schizophrenia
30. Effects of in vivo administration of kainic acid on the extracellular amino acid pool in the rabbit hippocampus
31. Localization of motor stimulant effects induced by intra-frontal cortex microinjections of CPP, a competitive NMDA receptor antagonist
32. B receptors in the rat central nervous system
33. Differential actions of dizocilpine (MK-801) on the mesolimbic and mesocortical dopamine systems: Role of neuronal activity
34. Reversal of phencyclidine effects by a group II metabotropic glutamate receptor agonist in rats
35. Glutamatergic regulation of GABA release in the prefrontal cortex during basal and stress activated conditions
36. Activation of glutamatergic neurotransmission by ketamine: A novel step in the pathway from NMDA receptor blockade to dopaminergic and cognitive disruptions associated with the prefrontal cortex
37. The neurobiological basis of prefrontal cortex self-stimulation: A review and an integrative hypothesis
38. Preferential stimulation of extracellular release of dopamine in rat frontal cortex to striatum following competitive inhibition of the N-methyl-D-aspartate receptor
39. Dysfunction of excitatory amino acidergic systems and schizophrenic disorders
40. Unique behavioral effects of the NMDA antagonist, CPP, upon injection into the medial pre-frontal cortex of rats
41. Hyperactivity induced by intra-frontal cortex injections of NMDA receptor antagonists: Evidence for pharmacological specificity and dopamine mediation
42. Ergometrine induced locomotor activity following intracerebral injection into the nucleus accumbens
43. In vivo demonstration of the enhancement of MK-801 by L-glutamate
44. B receptor agonists and antagonists
45. Dysfunctional brain dopamine systems induced by psychotomimetic NMDA-receptor antagonists and the effects of antipsychotic drugs, Brain Res
46. 1-adrenoceptor antagonism
47. Electrical stimulation of the prefrontal cortex increases dopamine release in the nucleus accumbens of the rat: Modulation by metabotropic glutamate receptors
48. Regional differences in the in vivo regulation of the extracellular levels of noradrenaline and its metabolites in rat brain
49. NMDA receptor antagonists impair prefrontal cortex function as assessed via spatial delayed alternation in rats: Modulation by dopamine
50. 1 receptors
51. Involvement of γ-aminobutyric acid neurotransmission in phencyclidine-induced dopamine release in the medial prefrontal cortex